By engaging bilaterally with the US and the EU, Asian countries are likely to bear the brunt of the EU/US rivalry over geographical indications. In this context, it is in their interest to prioritize multilateralism and support negotiations in multilateral settings.

How can the UK handle the expected reduction in services exports (mainly, but not exclusively, financial) and, by extension, how can it fund its already structural trade deficit? Such aspects must surely form the basis of the agreements that will make the future development of Brexit possible.

The mistakes that led to Ukraine’s failed hedge of the EU and Russia serve as a cautionary tale to other states that similarly find themselves in regional security complexes (RSCs) that are anarchic, have a bi or multipolar power distribution, and have growing enmity between the great powers there.

Instead of relying on dangerous activities that can further exacerbate the conflict, the challenge is to encourage meaningful action through cooperation and interest alignment. Prolonging the tug-of-war while waiting for another ‘bumping incident’ to sort out the tensions is an unnecessary and dangerous gambit for two nuclear powers.

The concept of corporate role conceptions shows that corporate self-conception is influenced by a variety of actors. All of them – employees, financiers, consumers, policy makers, etc. – can contribute to changing the way in which MNCs define their function in global forest governance.

Echoing the voice of the United Nations Secretary-General, we need to move from international chaos to the construction of an international global community that is capable of meeting and solving tomorrow’s challenges.

The common messages of love in all major religions offer policy makers and practitioners an opportunity to communicate with various faith communities at a time of growing religious diversity in many countries using their deeply felt and internalized lexicon.

CEPI represents the first step towards Joseph Stiglitz’s vision, cited by Gubby, of a fund which provides large rewards for cures to common diseases such as malaria, and smaller rewards for rarer diseases or less innovative ‘me-too’ drugs (Stiglitz, BMJ, 333, 2006, pp. 1279–1280). As a fledgling organization facing a Goliath, it deserves international support in its dual goals of incentivizing innovation and ensuring equitable access to biomedical advances.